Three Graphs About Drugs

I alluded to these three graphs in a presentation today, so here they are. The first one shows the recent uptick in drugs being developed at all stages; the second shows how the number of new drugs in post-clinical stage is abysmal; and the the third shows the flat-line in new molecular entities (NMEs). (The first two graphs are courtesy of PharmaProjects, while the third is from Parexel.)




Related posts:

  1. The Blockbuster Model of Drugs is Dead
  2. Yes, We Have No New Drugs
  3. Baby Drugs are Big
  4. Insider Trading in Clinical Trials
  5. Traders on Drugs